FR2939030B1 - Utilisation de la taurine pour le traitement de la canitie - Google Patents

Utilisation de la taurine pour le traitement de la canitie

Info

Publication number
FR2939030B1
FR2939030B1 FR0858208A FR0858208A FR2939030B1 FR 2939030 B1 FR2939030 B1 FR 2939030B1 FR 0858208 A FR0858208 A FR 0858208A FR 0858208 A FR0858208 A FR 0858208A FR 2939030 B1 FR2939030 B1 FR 2939030B1
Authority
FR
France
Prior art keywords
taurine
canitia
treatment
canities
progression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0858208A
Other languages
English (en)
Other versions
FR2939030A1 (fr
Inventor
Albert Duranton
Francis Pruche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0858208A priority Critical patent/FR2939030B1/fr
Publication of FR2939030A1 publication Critical patent/FR2939030A1/fr
Application granted granted Critical
Publication of FR2939030B1 publication Critical patent/FR2939030B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention a pour objet l'utilisation cosmétique d'une quantité efficace de taurine et/ou l'un de ses dérivés et/ou de leurs sels acceptables pour prévenir, limiter ou arrêter la progression de la canitie.
FR0858208A 2008-12-02 2008-12-02 Utilisation de la taurine pour le traitement de la canitie Active FR2939030B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0858208A FR2939030B1 (fr) 2008-12-02 2008-12-02 Utilisation de la taurine pour le traitement de la canitie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0858208A FR2939030B1 (fr) 2008-12-02 2008-12-02 Utilisation de la taurine pour le traitement de la canitie

Publications (2)

Publication Number Publication Date
FR2939030A1 FR2939030A1 (fr) 2010-06-04
FR2939030B1 true FR2939030B1 (fr) 2011-05-06

Family

ID=40793047

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0858208A Active FR2939030B1 (fr) 2008-12-02 2008-12-02 Utilisation de la taurine pour le traitement de la canitie

Country Status (1)

Country Link
FR (1) FR2939030B1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010043069A1 (de) * 2010-10-28 2012-05-03 Henkel Ag & Co. Kgaa Verwendung von Purin und/oder einem Purinderivat und mindestens einer Aminosäure zur Beeinflussung des natürlichen Pigmentierungsprozesses
WO2017091797A1 (fr) 2015-11-24 2017-06-01 L'oreal Compositions pour le traitement des cheveux
RU2771234C2 (ru) 2015-11-24 2022-04-28 Л'Ореаль Композиции для обработки волос
WO2017117480A1 (fr) 2015-12-31 2017-07-06 Colgate-Palmolive Company Compositions de nettoyage
US11135150B2 (en) 2016-11-21 2021-10-05 L'oreal Compositions and methods for improving the quality of chemically treated hair
US11433011B2 (en) 2017-05-24 2022-09-06 L'oreal Methods for treating chemically relaxed hair
CN113616552A (zh) 2017-12-29 2021-11-09 欧莱雅 用于改变毛发颜色的组合物
US11090249B2 (en) 2018-10-31 2021-08-17 L'oreal Hair treatment compositions, methods, and kits for treating hair
US11419809B2 (en) 2019-06-27 2022-08-23 L'oreal Hair treatment compositions and methods for treating hair

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1616551A1 (fr) * 2004-07-13 2006-01-18 L'oreal Procédé de traitement cosmétique pour prévenir ou retarder les signes du vieillissement cutané
CN1803059A (zh) * 2005-12-29 2006-07-19 张根芳 一种保健发簪、髻及其制造方法
CN1803060A (zh) * 2005-12-29 2006-07-19 张根芳 一种保健梳及其制造方法
EP1932509A1 (fr) * 2006-12-14 2008-06-18 L'oreal Utilisation orale d'au moins un acide gras monoinsaturé pour améliorer la chevelure
JP5078369B2 (ja) * 2007-01-18 2012-11-21 株式会社 資生堂 頭髪用組成物及び抗白髪剤

Also Published As

Publication number Publication date
FR2939030A1 (fr) 2010-06-04

Similar Documents

Publication Publication Date Title
FR2939030B1 (fr) Utilisation de la taurine pour le traitement de la canitie
MA35920B1 (fr) Composés destinés au traitement de l'amyotrophie spinale
MA42164A1 (fr) Composes biheteroaryle et leurs utilisations
MA42410B1 (fr) Oxystérols et leurs méthodes d'utilisation
FR2938437B1 (fr) Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
MX2018010192A (es) Inhibidores de glucosidasa.
MA45598B1 (fr) Stéroles 24-hydroxylés substitués en position 11 pour le traitement des maladies liées au récepteur nmda
MA38810B1 (fr) Inhibiteurs de rorc2 méthodes d'utilisation associées
FR3066388B1 (fr) Composition cosmetique comprenant des extraits de rose
PH12013500913A1 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
MA32904B1 (fr) Composes de purine
MX2018010191A (es) Inhibidores de glucosidasa.
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
EA201000297A1 (ru) Конденсированные бициклические имидазолы
BR112014028041A2 (pt) tratamento de obesidade hipotalâmica com inibidores de metap2
MA46490A1 (fr) Dérivés de nucléosides 4'- fluoro-2' - méthyle substitués
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
MA33743B1 (fr) Compositions comprenant du tramadol et du célécoxib dans le traitement de la douleur
FR2959128B1 (fr) Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement des odeurs corporelles
DK2046378T3 (da) Anvendelse af bakterielle polysaccharider til biofilminhibering
MA33457B1 (fr) L-sérine pour son utilisation en tant que médicament pour prévenir et/ou traiter une réaction inflammatoire de la peau
MA39170B1 (fr) Composes inhibiteurs de sérine/thréonine kinase pour leurs utilisations dans le traitement du cancer
MA31435B1 (fr) Inhibition de metastases tumorales par des anticoprs anti-neuropiline 2
MA34968B1 (fr) Urées asymétriques et utilisations médicales de celles-ci
MA41730B1 (fr) Utilisation de dérivé de benzimidazole pour l'acidité nocturne

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16